Bowhead Specialty (NYSE:BOW – Get Free Report) issued an update on its third quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.36-0.39 for the period, compared to the consensus estimate of $0.32.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on BOW. JMP Securities lifted their price target on shares of Bowhead Specialty from $31.00 to $32.00 and gave the company a “market outperform” rating in a report on Tuesday, October 15th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $32.00 target price on shares of Bowhead Specialty in a report on Wednesday, August 7th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Bowhead Specialty currently has an average rating of “Hold” and a consensus target price of $29.40.
Check Out Our Latest Stock Report on Bowhead Specialty
Bowhead Specialty Price Performance
Bowhead Specialty (NYSE:BOW – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.27 by $0.01. The company had revenue of $98.90 million during the quarter, compared to analysts’ expectations of $94.28 million. The company’s quarterly revenue was up 51.0% compared to the same quarter last year. Research analysts anticipate that Bowhead Specialty will post 1.3 EPS for the current fiscal year.
Bowhead Specialty Company Profile
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Stories
- Five stocks we like better than Bowhead Specialty
- The Basics of Support and Resistance
- Is CoStar Group Stock a Buy Before Earnings? Analysts Think So
- How Can Investors Benefit From After-Hours Trading
- 3 Stocks Driving the Shift to Nuclear Energy for AI Power
- How to Invest in the Best Canadian StocksĀ
- Utilities Outperform in 2024: 3 Stocks to Keep on Your Radar
Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.